The preparation of
two polyarginine conjugates of the complex Os(II)
[bis-(4′-(4-carboxyphenyl)-2,2′:6′,2″-terpyridine)]
[Os-(R
n
)
2
]
x
+
(
n
= 4 and 8;
x
= 10 and
18) is reported, to explore whether the R8 peptide sequence that promotes
cell uptake requires a contiguous amino acid sequence for membrane
permeation or if this can be accomplished in a linearly bridged structure
with the additive effect of shorter peptide sequences. The conjugates
exhibit NIR emission centered at 754 nm and essentially oxygen-insensitive
emission with a lifetime of 89 ns in phosphate-buffered saline. The
uptake, distribution, and cytotoxicity of the parent complex and peptide
derivatives were compared in 2D cell monolayers and a three-dimensional
(3D) multicellular tumor spheroid (MCTS) model. Whereas, the bis-octaarginine
sequences were impermeable to cells and spheroids, and the bis-tetraarginine
conjugate showed excellent cellular uptake and accumulation in two
2D monolayer cell lines and remarkable in-depth penetration of 3D
MCTSs of pancreatic cancer cells. Overall, the data indicates that
cell permeability can be promoted via non-contiguous sequences of
arginine residues bridged across the metal centre.
We report the synthesis and biochemical evaluation of compounds that are designed as hybrids of the microtubule targeting benzophenone phenstatin and the aromatase inhibitor letrozole. A preliminary screening in estrogen receptor (ER)-positive MCF-7 breast cancer cells identified 5-((2H-1,2,3-triazol-1-yl)(3,4,5-trimethoxyphenyl)methyl)-2-methoxyphenol 24 as a potent antiproliferative compound with an IC50 value of 52 nM in MCF-7 breast cancer cells (ER+/PR+) and 74 nM in triple-negative MDA-MB-231 breast cancer cells. The compounds demonstrated significant G2/M phase cell cycle arrest and induction of apoptosis in the MCF-7 cell line, inhibited tubulin polymerisation, and were selective for cancer cells when evaluated in non-tumorigenic MCF-10A breast cells. The immunofluorescence staining of MCF-7 cells confirmed that the compounds targeted tubulin and induced multinucleation, which is a recognised sign of mitotic catastrophe. Computational docking studies of compounds 19e, 21l, and 24 in the colchicine binding site of tubulin indicated potential binding conformations for the compounds. Compounds 19e and 21l were also shown to selectively inhibit aromatase. These compounds are promising candidates for development as antiproliferative, aromatase inhibitory, and microtubule-disrupting agents for breast cancer.
Tridentate ligand-coordinated ruthenium (II) polypyridyl complexes with large N−Ru−N bite angles have been shown to promote ligand field splitting and reduce singlet−triplet state mixing leading to dramatically extended emission quantum yields and lifetimes under ambient conditions. These effects are anticipated to enhance their photoinduced singlet oxygen production, promoting prospects for such complexes as type II phototherapeutics. In this contribution, we examined this putative effect for [Ru(bqp)(bqpCOOEt)] 2+ , Ru-bqp-ester, a heteroleptic complex containing bqp = [2,6-bi(quinolin-8-yl)pyridine], a wellestablished large bite angle tridentate ligand, as well as its peptide conjugates [Ru(bqp)(bqpCONH-ahx-FrFKFrFK(Ac)-CONH 2 )] 5+ (Ru-bqp-MPP) and [Ru(bqp) (bqp)(CONH-ahx-RRRRRRRR-CONH 2 )] 10+ (Ru-bqp-R8) that were prepared in an effort to promote live cell/tissue permeability and targeting of the parent. Membrane permeability of both parent and peptide conjugates were compared across 2D cell monolayers; A549, Chinese hamster ovary, human pancreatic cancer (HPAC), and 3D HPAC multicellular tumor spheroids (MCTS) using confocal microscopy. Both the parent complex and peptide conjugates showed exceptional permeability with rapid uptake in both 2D and 3D cell models but with little distinction in permeability or distribution in cells between the parent or peptide conjugates. Unexpectedly, the uptake was temperature independent and so attributed to passive permeation. Both dark and photo-toxicity of the Ru(II) complexes were assessed across cell types, and the parent showed notably low dark toxicity. In contrast, the parent and conjugates were found to be highly phototoxic, with impressive phototoxic indices (PIs) toward HPAC cell monolayers in particular, with PI values ranging from ∼580 to 760. Overall, our data indicate that the Ru(II) parent complex and its peptide conjugates show promise at both cell monolayers and 3D MCTS as photosensitizers for photodynamic therapy.
Pancreatic cancer is a highly lethal disease. Therapeutic resistance to chemotherapy is a major cause of treatment failure and recurrence in pancreatic cancer. Organoids derived from cancer stem cells (CSC) are promising models for the advancement of personalised therapeutic responses to inform clinical decisions. However, scaling-up of 3D organoids for high-throughput screening is time-consuming and costly. Here, we successfully developed organoid-derived cell lines (2.5D) from 3D organoids; the cells were then expanded and recapitulated back into organoids known as cell line organoids (CLOs). The 2.5D lines were cultured long term into 2D established cell lines for downstream comparison analysis. Experimental characterisation of the models revealed that the proliferation of CLOs was slightly faster than that of parental organoids. The therapeutic response to chemotherapeutic agents in 3D CLOs and organoids showed a similar responsive profile. Compared to 3D CLOs and organoids, 2D cell lines tended to be less responsive to all the drugs tested. Stem cell marker expression was higher in either 3D CLOs or organoids compared to 2D cell lines. An in vivo tumorigenicity study found CLOs form tumours at a similar rate to organoids and retain enhanced CSC marker expression, indicating the plasticity of CSCs within the in vivo microenvironment.
Chronic lymphocytic leukaemia (CLL) is the most commonly diagnosed leukaemia in the Western world, with an average age of diagnosis being over 65 years 1, 2. Despite development of new targeted therapeutics; emerging resistance, pharmacoeconomic sustainability and side-effect intolerability remain significant barriers to patient care and potential disease curability Chemical Synthesis Scheme & Figure 1: Synthesis of ethanoanthracene-based analogues with α,β-unsaturated carbonyl motif (blue) via a two-step process involving Claisen Schmidt condensation followed by Diels Alder cycloaddition onto tricyclic anthracene core (red) to create ethanoanthracene derivatives. The tail groups (purple) and head groups (green) used are outlined above. Biochemical Evaluation & SAR Elucidation Prior research with 2-nitrovinylanthracenes showed strong anti-proliferative proapoptototic activity in CLL lines (Fig. 2): PGA-1 (mutated Ig VH; good prognosis) and HG-3 (unmutated Ig VH; poor prognosis).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.